No Data
No Data
Hong Kong Stock Afternoon Review | All three major Indexes fell, the technology index dropped over 4%; Network Technology stocks weakened, Meituan fell over 7%; some Golden Industrial Concept stocks rose against the trend, Chifeng Jilong Gold Mining incre
Network Technology stocks fell broadly, with MEITUAN-W down 7.43% and KUAISHOU-W down 6.25%; most Apple Supplier stocks also declined, COWELL down 6.83% and AAC TECH down 5.77%; Autos stocks fell broadly, with LEAPMOTOR down 7.87% and XPENG-W down 7.87%.
Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models
Fangzhou Widens Loss in 2024
Press Release: Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation
Ark Health's stock price rose over 8%. The revenue for 2024 is 2.707 billion yuan, an increase of 11.2% year-on-year.
Ark Health (06086) saw its stock price rise by 8.67% after the earnings report, currently at HK$5.89, with a trading volume of HK$13.1188 million. On March 23, Ark Health (06086) released its performance announcement for the year ending December 31, 2024. In 2024, the company's revenue is expected to grow by 11.2% compared to 2023, reaching 2.707 billion yuan, mainly benefiting from increases in revenue from offline retail pharmacy services, wholesale, and customized content and marketing solutions.
A forward-looking layout of "AI + Medical", adjusted Net income increased by 139% year-on-year. Technological innovation boosts Ark Health (06086) profit surge.
Amidst the waves of change, opportunities arise. Who is leading in AI + Digital Health? Companies that adhere to long-term development principles have provided the answer with impressive annual performance. On March 21, "the first stock of AI chronic disease management" Ark Health (06086) officially released its first annual report since going public.